ANALYSIS OF EARLY WING VEIN DEVELOPMENT IN DROSPHILIA
ANALYSIS OF EARLY WING VEIN DEVELOPMENT IN DROSPHILIA
批准号:
6837350
负责人:
ETHAN BIER
金额:
$7.56万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-01-01 至 2004-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (adapted from investigator's abstract): The long term goal of this
proposal is to understand how wing vein development is initiated in Drosophila
wing imaginal discs. Five major veins run the length of the Drosophila wing. We
have proposed that wing vein development is initiated at boundaries between
distinct domains of cells situated along the anterior-posterior (A/P) axis of
the wing imaginal disc in third instar larvae. In our convincing case for this
hypothesis, we have provided a variety of evidence indicating that development
of the second longitudinal vein (L2) is induced just anterior to a broad
central domain of cells expressing a zinc finger transcription factor known as
spalt- major (salm). We have proposed that salm expressing cells send a signal
to adjacent anterior cells to activate expression of hormonereceptor family
transcription factors encoded by genes at the knirpslknirps-related (kni/knrl)
locus. The kni and knrl genes then function to organize gene expression in and
around the L2 vein primordium. In this proposal we seek to understand the
mechanism by which salm expressing cells activate kni and knrl expression in
neighboring anterior cells by analyzing an enhancer element of the knilknrl
locus which drives expression in the L2 primordium. We also propose to
investigate the regulation of a second gene, abrupt (ab), which functions to
organize formation of the L5 vein. In a key experiment, we propose to determine
whether the kni~nrl and ab genes define specific vein types (i.e. L2 versus L5)
or whether they function more generally in promoting vein versus intervein
fates. These studies are of broad medical relevance to understanding the basis
of birth defects. As defects in cell-cell signaling are involved in disease
states such as cancer, the proposed studies also are relevant to such diseases
since development of the L2 vein depends critically on cell-cell communication.
In addition, the TGF-8 related signaling and EGF-R signaling pathways play
prominent roles in maintaining and refining the vein pattern. Because
mis-regulation of these known pathways causes aggressive forms of cancer,
understanding the regulation of these pathways also is of significant relevance
to cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Analysis of homolog-based CRISPR editing in somatic cells
-
批准号:10343429
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2022
-
负责人:ETHAN BIER
-
依托单位:
Analysis of homolog-based CRISPR editing in somatic cells
-
批准号:10676726
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2022
-
负责人:ETHAN BIER
-
依托单位:
Development of next-generation gene drive technologies for Anopheles population engineering
-
批准号:10278897
-
项目类别:
-
资助金额:$44.43万
-
财政年份:2021
-
负责人:ETHAN BIER
-
依托单位:
Development of next-generation gene drive technologies for Anopheles population engineering
-
批准号:10624305
-
项目类别:
-
资助金额:$46.26万
-
财政年份:2021
-
负责人:ETHAN BIER
-
依托单位:
Development of next-generation gene drive technologies for Anopheles population engineering
-
批准号:10408862
-
项目类别:
-
资助金额:$44.44万
-
财政年份:2021
-
负责人:ETHAN BIER
-
依托单位:
The mutagenic chain reaction: a method for autocatalyic gene dissemination
-
批准号:10211352
-
项目类别:
-
资助金额:$32.36万
-
财政年份:2016
-
负责人:ETHAN BIER
-
依托单位:
The mutagenic chain reaction: a method for autocatalyic gene dissemination
-
批准号:9009589
-
项目类别:
-
资助金额:$30.61万
-
财政年份:2016
-
负责人:ETHAN BIER
-
依托单位:
The mutagenic chain reaction: a method for autocatalyic gene dissemination
-
批准号:10395549
-
项目类别:
-
资助金额:$32.39万
-
财政年份:2016
-
负责人:ETHAN BIER
-
依托单位:
The mutagenic chain reaction: a method for autocatalyic gene dissemination
-
批准号:10614935
-
项目类别:
-
资助金额:$32.39万
-
财政年份:2016
-
负责人:ETHAN BIER
-
依托单位:
Mutagenic chain reaction-facilitated immunotherapy
-
批准号:9163059
-
项目类别:
-
资助金额:$65.1万
-
财政年份:2016
-
负责人:ETHAN BIER
-
依托单位:
Mutagenic chain reaction-facilitated immunotherapy
-
批准号:9755350
-
项目类别:
-
资助金额:$65.1万
-
财政年份:2016
-
负责人:ETHAN BIER
-
依托单位:
Analyzing a novel mechanism of action of bacterial cAMP producing toxins
-
批准号:8998800
-
项目类别:
-
资助金额:$53.79万
-
财政年份:2014
-
负责人:ETHAN BIER
-
依托单位:
Analyzing a novel mechanism of action of bacterial cAMP producing toxins
-
批准号:9416066
-
项目类别:
-
资助金额:$53.79万
-
财政年份:2014
-
负责人:ETHAN BIER
-
依托单位:
Analyzing a novel mechanism of action of bacterial cAMP producing toxins
-
批准号:8796696
-
项目类别:
-
资助金额:$53.79万
-
财政年份:2014
-
负责人:ETHAN BIER
-
依托单位:
Analyzing a novel mechanism of action of bacterial cAMP producing toxins
-
批准号:8673121
-
项目类别:
-
资助金额:$53.79万
-
财政年份:2014
-
负责人:ETHAN BIER
-
依托单位:
The Molecular Genetics of Early Neurogenesis
-
批准号:8678233
-
项目类别:
-
资助金额:$39.23万
-
财政年份:2013
-
负责人:ETHAN BIER
-
依托单位:
Analyzing Anthrox Toxins in Drosophila
-
批准号:7534979
-
项目类别:
-
资助金额:$38.04万
-
财政年份:2007
-
负责人:ETHAN BIER
-
依托单位:
Analyzing Anthrox Toxins in Drosophila
-
批准号:8197012
-
项目类别:
-
资助金额:$37.17万
-
财政年份:2007
-
负责人:ETHAN BIER
-
依托单位:
Analyzing Anthrox Toxins in Drosophila
-
批准号:7995943
-
项目类别:
-
资助金额:$37.21万
-
财政年份:2007
-
负责人:ETHAN BIER
-
依托单位:
Analyzing Anthrox Toxins in Drosophila
-
批准号:7382924
-
项目类别:
-
资助金额:$38.07万
-
财政年份:2007
-
负责人:ETHAN BIER
-
依托单位:
国内基金
海外基金
登录
查看更多内容
RGD-68Ga@AuNCs PET监测PRMT5通过VEGFA调节肺腺癌血管新生的功能及机制
-
批准号:82372007
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:谢文晖
-
依托单位:
PROCR信号通路介导的血管新生在卵巢组织移植中的作用及机制研究
-
批准号:82371726
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:李文
-
依托单位:
RNA编辑型IGFBP7在肿瘤细胞与肿瘤血管微环境中的调控作用及机制研究
-
批准号:32070790
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:徐小燕
-
依托单位:
ROBO4对视网膜血管生成(angiogenesis)的调控及其分子机制
-
批准号:81200692
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2012
-
负责人:陈凌
-
依托单位:
基于新生血管显像研究MSC治疗缺血性脑血管病的转化医学关键问题
-
批准号:81171370
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:朱朝晖
-
依托单位:
探索VASH2转录激活对肝细胞癌血管生成和上皮间质转化的作用及机制
-
批准号:81172267
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:高文涛
-
依托单位:
解析miR-566调控VHL/β-catenin信号通路影响人脑胶质瘤血管新生的分子机制
-
批准号:81101916
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:周旋
-
依托单位:
脂肪组织来源干细胞促进颗粒脂肪游离移植后再血管化机制的实验研究
-
批准号:81171834
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:鲁峰
-
依托单位:
99mTc-3PRGD2 SPECT显像用于评价肺癌抗新生血管药物疗效的动物研究及肺癌诊断临床研究
-
批准号:81171369
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:李方
-
依托单位:
核素靶向示踪肿瘤新生血管作用位点研究
-
批准号:81071183
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2010
-
负责人:王荣福
-
依托单位: